Globus Medical Inc. GMED
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Revenue | $2.9B | +17% | FY ending Dec 31, 2025 |
|---|---|---|---|
| Gross profit | $1.0B | +34% | FY ending Dec 31, 2023 |
| Operating income | $479.8M | +189% | FY ending Dec 31, 2025 |
| Net income | $537.9M | +422% | FY ending Dec 31, 2025 |
| Earnings per share | $3.92 | +423% | FY ending Dec 31, 2025 |
| Research & development | $147.2M | -10% | FY ending Dec 31, 2025 |
| Cash from operations | $753.4M | +45% | FY ending Dec 31, 2025 |
| Capital spending | $164.7M | +43% | FY ending Dec 31, 2025 |
| Share buybacks | $300.5M | +250% | FY ending Dec 31, 2025 |
| Cash | $526.2M | -33% | FY ending Dec 31, 2025 |
| Shareholders' equity | $4.6B | +9% | FY ending Dec 31, 2025 |
| Shares outstanding | 100M | +1% | FY ending Dec 31, 2019 |
Insider trades
Last 12 months: 0 open-market buys ($0) and 14 sales ($17.5M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| James R TobinDirector | Sold | 30,000 | $74.58 | $2.2M | Sep 15, 2026 |
| Stephen T ZarrilliDirector | Sold | 25,000 | $87.04 | $2.2M | Aug 18, 2026 |
| David D DavidarDirector | Sold | 25,000 | $80.76 | $2.0M | Jun 5, 2026 |
| Kelly HullerEVP, GC, Corporate Secretary | Soldpre-set plan | 20,000 | $94.50 | $1.9M | Feb 25, 2026 |
| Kelly HullerEVP, GC, Corporate Secretary | Soldpre-set plan | 10,000 | $87.67 | $877K | Feb 12, 2026 |
| Kyle KlineSenior Vice President, CFO | Soldpre-set plan | 3,594 | $101.10 | $363K | Jan 8, 2026 |
| Leslie V NorwalkDirector | Soldpre-set plan | 2,000 | $101.10 | $202K | Jan 8, 2026 |
| Leslie V NorwalkDirector | Soldpre-set plan | 4,000 | $88.85 | $355K | Dec 12, 2025 |
| Kyle KlineSenior Vice President, CFO | Soldpre-set plan | 18,542 | $90.00 | $1.7M | Dec 1, 2025 |
| Kelly HullerSVP, GC, Corporate Secretary | Soldpre-set plan | 7,500 | $90.00 | $675K | Nov 25, 2025 |
| David D DavidarDirector | Sold | 25,000 | $86.00 | $2.2M | Nov 12, 2025 |
| Stephen T ZarrilliDirector | Sold | 25,000 | $84.29 | $2.1M | Nov 11, 2025 |
| Ann D RhoadsDirector | Soldpre-set plan | 2,000 | $85.00 | $170K | Nov 10, 2025 |
| Ann D RhoadsDirector | Soldpre-set plan | 8,000 | $81.00 | $648K | Nov 7, 2025 |
Other insider moves (14): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| James R TobinDirector | Option exercise2 fills | 30,000 | $58.72 avg | $1.8M | Sep 15, 2026 |
| Stephen T ZarrilliDirector | Option exercise | 25,000 | $53.27 | $1.3M | Aug 18, 2026 |
| David D DavidarDirector | Gift | 2,500 | – | – | Jul 27, 2026 |
| David D DavidarDirector | Option exercise | 25,000 | $26.27 | $657K | Jun 5, 2026 |
| Ann D RhoadsDirector | Option exercise | 25,000 | $26.27 | $657K | Jun 4, 2026 |
| Kelly HullerEVP, GC, Corporate Secretary | Option exercisepre-set plan | 20,000 | $43.58 | $872K | Feb 25, 2026 |
| Kelly HullerEVP, GC, Corporate Secretary | Option exercisepre-set plan | 10,000 | $45.64 | $456K | Feb 12, 2026 |
| Kyle KlineSenior Vice President, CFO | Option exercisepre-set plan | 3,594 | $51.87 | $186K | Jan 8, 2026 |
| David C PaulExecutive Chairman, Director, 10% owner | Option exercise | 34,375 | $25.52 | $877K | Dec 8, 2025 |
| Kyle KlineSenior Vice President, CFO | Option exercisepre-set plan4 fills | 18,542 | $59.86 avg | $1.1M | Dec 1, 2025 |
| Kelly HullerSVP, GC, Corporate Secretary | Option exercisepre-set plan | 7,500 | $25.96 | $195K | Nov 25, 2025 |
| David D DavidarDirector | Option exercise | 25,000 | $25.52 | $638K | Nov 12, 2025 |
| Stephen T ZarrilliDirector | Option exercise | 25,000 | $44.14 | $1.1M | Nov 11, 2025 |
| David D DavidarDirector | Gift | 6,100 | – | – | Jan 2, 2025 |
Trades by members of Congress
3 members reported 4 buys and 3 sales since Apr 9, 2025. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Sep 3, 2026 | Oct 12, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $15K–$50K | Aug 19, 2026 | Sep 10, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Mar 3, 2026 | Apr 7, 2026 | Self |
| Lisa C. McClain R | Sold | $1,001–$15K | Jul 10, 2025 | Aug 13, 2025 | Spouse |
| Lisa C. McClain R | Sold some | $1,001–$15K | Jun 24, 2025 | Aug 13, 202550 days later | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Jun 17, 2025 | Aug 13, 202557 days later | Spouse |
| Josh Gottheimer D | Sold some | $1,001–$15K | Apr 9, 2025 | May 14, 2025 | Joint |
Latest SEC filings
- Insider plans to sell 144 · Sep 15, 2026
- Insider plans to sell 144 · Aug 18, 2026
- Quarterly report 10-Q · Aug 6, 2026
- News filing: Quarterly results 8-K · Aug 6, 2026
- Insider plans to sell 144 · Jun 5, 2026
- News filing: Executive or board change, Shareholder vote results 8-K · Jun 4, 2026
- Quarterly report 10-Q · May 7, 2026
- News filing: Quarterly results 8-K · May 7, 2026
- Shareholder meeting proxy DEF 14A · Apr 24, 2026
- Insider plans to sell 144 · Apr 14, 2026
- News filing: Executive or board change, Public announcement (Reg FD) 8-K · Mar 23, 2026
- Insider plans to sell 144 · Feb 25, 2026
- Annual report 10-K · Feb 24, 2026
- News filing: Quarterly results 8-K · Feb 24, 2026
- Insider plans to sell 144 · Feb 12, 2026
- Insider plans to sell 144 · Jan 8, 2026
- Insider plans to sell 144 · Jan 8, 2026
- News filing: Quarterly results 8-K · Jan 7, 2026
- Insider plans to sell 144 · Dec 12, 2025
- Insider plans to sell 144 · Dec 1, 2025
- Insider plans to sell 144 · Nov 25, 2025
- Insider plans to sell 144 · Nov 12, 2025
- Insider plans to sell 144 · Nov 12, 2025
- Insider plans to sell 144 · Nov 10, 2025
- Insider plans to sell 144 · Nov 7, 2025
About Globus Medical Inc.
Business description
- Industry
- Surgical & Medical Instruments & Apparatus
- Sector
- Industrial Applications and Services
- Headquarters
- Audubon, PA
- Incorporated in
- DE
- Fiscal year ends
- December 31
- Exchange
- NYSE
- Filer size
- Large accelerated filer
- SEC company number (CIK)
- 1237831
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.